Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002)
Clinical trial NCT02584478 · UNKNOWN
Trial details
- NCT number
- NCT02584478
- Sponsor
- Advenchen Laboratories, LLC
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2024-10-01
- Enrollment
- 294
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.